Advertisement

FDA bans Dengvaxia

The Food and Drug Administration (FDA) has banned the sale and distribution of Dengvaxia.

This comes after the Paris-based manufacturer of the anti-dengue vaccine found that it can cause severe reactions to persons who have not contracted dengue.

The FDA has also ordered Sanofi in the Philippines to conduct an information campaign on the issue.

The agency is calling on health professionals and the public to help government gather information on the conditions of persons who have previously received shots of Dengvaxia.

Topics: Sanofi , Dengvaxia , health , FDA
COMMENT DISCLAIMER: Reader comments posted on this Web site are not in any way endorsed by Manila Standard. Comments are views by manilastandard.net readers who exercise their right to free expression and they do not necessarily represent or reflect the position or viewpoint of manilastandard.net. While reserving this publication’s right to delete comments that are deemed offensive, indecent or inconsistent with Manila Standard editorial standards, Manila Standard may not be held liable for any false information posted by readers in this comments section.
AdvertisementKPPI
Advertisement